Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, April 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 88 articles:
HTML format


 

Single Articles

  1. CHA RR, Kim JH, Koo HS, Jung KW, et al
    Self-reported Non-celiac Gluten Sensitivity in the Korean Population: Demographic and Clinical Characteristics.
    J Neurogastroenterol Motil. 2022;28:283-290.
    PubMed    
    Abstract available

  2. LI Y, Liu N, Ge Y, Yang Y, et al
    Tryptophan and the innate intestinal immunity: Crosstalk between metabolites, host innate immune cells and microbiota.
    Eur J Immunol. 2022 Apr 1. doi: 10.1002/eji.202149401.
    PubMed    
    Abstract available

  3. PIRIYAKITPHAIBOON V, Sirinam S, Noipayak P, Sirivichayakul C, et al
    Risk Factors for Recurrent Abdominal Pain in Children with Nonorganic Acute Abdominal Pain.
    Pediatr Gastroenterol Hepatol Nutr. 2022;25:129-137.
    PubMed    
    Abstract available

  4. FOWLER S, Hoedt EC, Talley NJ, Keely S, et al
    Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions.
    Front Neurosci. 2022;16:825246.
    PubMed    
    Abstract available

  5. XIE CR, Tang B, Shi YZ, Peng WY, et al
    Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis.
    Front Pharmacol. 2022;13:853011.
    PubMed    
    Abstract available

  6. HANEVIK K, Saghaug C, Aaland M, Morch K, et al
    No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection.
    JGH Open. 2022;6:185-188.
    PubMed    
    Abstract available

  7. VAN THIEL IAM, Stavrou AA, de Jong A, Theelen B, et al
    Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome.
    Sci Rep. 2022;12:5391.
    PubMed    
    Abstract available

  8. KENDLER KS, Rosmalen JGM, Ohlsson H, Sundquist J, et al
    A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression.
    Psychol Med. 2022 Mar 31:1-8. doi: 10.1017/S0033291722000526.
    PubMed    
    Abstract available

  9. BURNS GL, Talley NJ, Keely S
    Immune responses in the irritable bowel syndromes: time to consider the small intestine.
    BMC Med. 2022;20:115.
    PubMed    
    Abstract available

  10. ZHANG HY, Zhang Y, Zhang Y, Jiang ZP, et al
    ROS-responsive thioketal-linked alginate/chitosan carriers for irritable bowel syndrome with diarrhea therapy.
    Int J Biol Macromol. 2022 Mar 26. pii: S0141-8130(22)00588.
    PubMed    
    Abstract available

  11. JASON LA, Cotler J, Islam MF, Furst J, et al
    Predictors for Developing Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Following Infectious Mononucleosis.
    J Rehabil Ther. 2022;4:1-5.
    PubMed    
    Abstract available

  12. TIAN YQ, Li JH, Li YC, Xu YC, et al
    Overexpression of GRK6 alleviates chronic visceral hypersensitivity through downregulation of P2Y6 receptors in anterior cingulate cortex of rats with prenatal maternal stress.
    CNS Neurosci Ther. 2022 Mar 29. doi: 10.1111/cns.13827.
    PubMed    
    Abstract available

  13. SIAJUNBORIBOON S, Tanpowpong P, Empremsilapa S, Lertudomphonwanit C, et al
    Prevalence of functional abdominal pain disorders and functional constipation in adolescents.
    J Paediatr Child Health. 2022 Mar 29. doi: 10.1111/jpc.15950.
    PubMed    
    Abstract available

  14. JOSE S, Devi SS, Sajeev A, Girisa S, et al
    Repurposing FDA Approved Drugs as FXR Agonists: A Structure Based in silico Pharmacological Study.
    Biosci Rep. 2022 Mar 29. pii: 231090. doi: 10.1042/BSR20212791.
    PubMed    
    Abstract available

  15. BASPINAR MM, Basat O
    Frequency and severity of irritable bowel syndrome in cigarette smokers, Turkey 2019.
    Tob Induc Dis. 2022;20:27.
    PubMed    
    Abstract available

  16. JOUKAR F, Yeganeh S, Shafaghi A, Mahjoob A, et al
    The seroprevalence of celiac disease in patients with symptoms of irritable bowel syndrome: A cross-sectional study in north of Iran.
    Hum Antibodies. 2022 Mar 16. pii: HAB211516. doi: 10.3233/HAB-211516.
    PubMed    
    Abstract available

  17. LI DJ, Chen MH, Bai YM, Tsai SJ, et al
    Risk of Pain Disorders in Offspring of Parents with Substance Use Disorders.
    Psychiatry Clin Neurosci. 2022 Mar 27. doi: 10.1111/pcn.13357.
    PubMed    
    Abstract available

  18. DI NARDO G, Cremon C, Staiano A, Stanghellini V, et al
    Role of inflammation in pediatric irritable bowel syndrome.
    Neurogastroenterol Motil. 2022 Mar 27:e14365. doi: 10.1111/nmo.14365.
    PubMed    
    Abstract available

  19. BALLOU S, Hassan R, Nee J, Iturrino J, et al
    Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline.
    Clin Gastroenterol Hepatol. 2022 Mar 23. pii: S1542-3565(22)00293.
    PubMed    
    Abstract available

  20. SCUDERI SA, Casili G, Lanza M, Ardizzone A, et al
    Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  21. KAMPHUIS JBJ, Reber LL, Eutamene H, Theodorou V, et al
    Increased fermentable carbohydrate intake alters colonic mucus barrier function through glycation processes and increased mast cell counts.
    FASEB J. 2022;36:e22297.
    PubMed    
    Abstract available

  22. RABAGO R, Bonilla A, Escamilla-Diego E, Higuera de la Tijera MF, et al
    Pictograms are more effective than verbal descriptors in Spanish for bloating and distension.
    Neurogastroenterol Motil. 2022 Apr 8:e14364. doi: 10.1111/nmo.14364.
    PubMed    
    Abstract available

  23. KUMBHARE SV, Francis-Lyon PA, Kachru D, Uday T, et al
    Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study.
    Front Microbiol. 2022;13:826916.
    PubMed    
    Abstract available

  24. UNALAN-ALTINTOP T, Vahabov C, Ergunay K, Kurt O, et al
    Investigation of Dientamoeba fragilis and Blastocystis in patients from Turkey with ulcerative colitis and irritable bowel syndrome: any relation with genotypes?
    Acta Trop. 2022 Apr 4:106451. doi: 10.1016/j.actatropica.2022.106451.
    PubMed    
    Abstract available

  25. GU Y, Li L, Yang M, Liu T, et al
    Bile acid-gut microbiota crosstalk in irritable bowel syndrome.
    Crit Rev Microbiol. 2022 Apr 7:1-20. doi: 10.1080/1040841X.2022.2058353.
    PubMed    
    Abstract available

  26. WENG ZJ, Hu SX, Zhang F, Zhang ZY, et al
    Spinal cord astrocyte P2X7Rs mediate the inhibitory effect of electroacupuncture on visceral hypersensitivity of rat with irritable bowel syndrome.
    Purinergic Signal. 2022 Apr 7. pii: 10.1007/s11302-021-09830.
    PubMed    
    Abstract available

  27. BIESIEKIERSKI JR, Tuck CJ
    Low FODMAP diet beyond IBS: Evidence for use in other conditions.
    Curr Opin Pharmacol. 2022;64:102208.
    PubMed    
    Abstract available

  28. KHAN EH, Ahamed F, Karim MR, Roy P, et al
    Psychiatric Morbidity in Irritable Bowel Syndrome.
    Mymensingh Med J. 2022;31:458-465.
    PubMed    
    Abstract available

  29. KLINGE MW, Krogh K, Mark EB, Drewes AM, et al
    Colonic volume in patients with functional constipation or irritable bowel syndrome determined by magnetic resonance imaging.
    Neurogastroenterol Motil. 2022 Apr 5:e14374. doi: 10.1111/nmo.14374.
    PubMed    
    Abstract available

  30. LEWANDOWSKI K, Kaniewska M, Karlowicz K, Rosolowski M, et al
    The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome.
    Prz Gastroenterol. 2022;17:28-34.
    PubMed    
    Abstract available

  31. HUANG HL, Xu HM, Liu YD, Shou DW, et al
    First Application of Fecal Microbiota Transplantation in Adult Asperger Syndrome With Digestive Symptoms-A Case Report.
    Front Psychiatry. 2022;13:695481.
    PubMed    
    Abstract available

  32. TAO E, Zhu Z, Hu C, Long G, et al
    Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome.
    Front Cell Neurosci. 2022;16:837166.
    PubMed    
    Abstract available

  33. SCHNEDL WJ, Meier-Allard N, Schenk M, Lackner S, et al
    Helicobacter pylori infection and lactose intolerance increase expiratory hydrogen.
    EXCLI J. 2022;21:426-435.
    PubMed    
    Abstract available

  34. HUANG WL, Chang SS, Liao SC
    The psychological features of distinct somatic syndromes: A cluster analysis according to population-based somatic symptom profiles in Taiwan.
    J Formos Med Assoc. 2022 Mar 30. pii: S0929-6646(22)00111.
    PubMed    
    Abstract available

  35. DEBRAS C, Chazelas E, Srour B, Julia C, et al
    Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Cancer Risk in the Prospective NutriNet-Sante Cohort.
    J Nutr. 2022;152:1059-1069.
    PubMed    
    Abstract available

  36. HUANG R, Wu F, Zhou Q, Wei W, et al
    Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications.
    Microbiol Res. 2022;260:127019.
    PubMed    
    Abstract available

  37. GIN GT
    Female Pelvic Conditions: Chronic Pelvic Pain.
    FP Essent. 2022;515:11-19.
    PubMed    
    Abstract available

  38. ISSRANI R, Reddy J, Dabah THE, Prabhu N, et al
    Role of Oral Microbiota in Carcinogenesis: A Short Review.
    J Cancer Prev. 2022;27:16-21.
    PubMed    
    Abstract available

  39. GALICA AN, Galica R, Dumitrascu DL
    Diet, fibers, and probiotics for irritable bowel syndrome.
    J Med Life. 2022;15:174-179.
    PubMed    
    Abstract available

  40. BAGAGIOLO D, Rosa D, Borrelli F
    Efficacy and safety of osteopathic manipulative treatment: an overview of systematic reviews.
    BMJ Open. 2022;12:e053468.
    PubMed    
    Abstract available

  41. WAN YP, Ng SM
    Hypnotherapy for persons with Irritable Bowel Syndrome: A three-arm randomized controlled trial.
    Am J Clin Hypn. 2022 Apr 12:1-26. doi: 10.1080/00029157.2022.2051424.
    PubMed    
    Abstract available

  42. BALLOU S, Haas JW, Iturrino J, Nee J, et al
    Psychological Predictors of Response to Open-label versus Double-blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome.
    Psychosom Med. 2022 Apr 12. pii: 00006842-990000000-00009.
    PubMed    
    Abstract available

  43. COWAN LM, Strege PR, Rusinova R, Andersen OS, et al
    Capsaicin as an amphipathic modulator of NaV1.5 mechanosensitivity.
    Channels (Austin). 2022;16:9-26.
    PubMed    
    Abstract available

  44. LOUWIES T, Greenwood-Van Meerveld B
    Chronic stress increases DNA methylation of the GR promoter in the central nucleus of the amygdala of female rats.
    Neurogastroenterol Motil. 2022 Apr 11:e14377. doi: 10.1111/nmo.14377.
    PubMed    
    Abstract available

  45. GHAFFARI P, Shoaie S, Nielsen LK
    Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions.
    J Transl Med. 2022;20:173.
    PubMed    
    Abstract available

  46. KIM J, Lee S, Rhew K
    Association between Gastrointestinal Diseases and Migraine.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  47. RYDELL N, Ekoff H, Hellstrom PM, Moverare R, et al
    Measurement of Serum IgG Anti-Integrin alphavbeta6 Autoantibodies Is a Promising Tool in the Diagnosis of Ulcerative Colitis.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  48. ACCARIE A, Toth J, Wauters L, Farre R, et al
    Estrogens Play a Critical Role in Stress-Related Gastrointestinal Dysfunction in a Spontaneous Model of Disorders of Gut-Brain Interaction.
    Cells. 2022;11.
    PubMed    
    Abstract available

  49. LIU Y, Chen M
    Insights into the underlying mechanisms and clinical management of microscopic colitis in relation to other gastrointestinal disorders.
    Gastroenterol Rep (Oxf). 2022;10:goac011.
    PubMed    
    Abstract available

  50. REJ A, Buckle RL, Shaw CC, Trott N, et al
    National survey evaluating the provision of gastroenterology dietetic services in England.
    Frontline Gastroenterol. 2020;12:380-384.
    PubMed    
    Abstract available

  51. VOLLERT J, Wang R, Regis S, Yetman H, et al
    Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.
    Front Psychiatry. 2022;13:842030.
    PubMed    
    Abstract available

  52. OTANI K, Watanabe T, Takahashi K, Ominami M, et al
    A questionnaire-based survey on the etiopathogenesis of chronic constipation during a medical check-up in Japan.
    J Clin Biochem Nutr. 2022;70:205-211.
    PubMed    
    Abstract available

  53. SWIER RM, Siebrasse A, Coscia E, Peery AF, et al
    Diet in Benign Colonic Disorders: A Narrative Review.
    Clin Ther. 2022 Apr 7. pii: S0149-2918(22)00114.
    PubMed    
    Abstract available

  54. GOTA CE
    Fibromyalgia: Recognition and Management in the Primary Care Office.
    Rheum Dis Clin North Am. 2022;48:467-478.
    PubMed    
    Abstract available

  55. TANG R, Peng X, Zhou X, Zheng Z, et al
    Mechanism of the Treatment of Irritable Bowel Syndrome with Sini Powder and Tong Xie Yao Fang Decoction Based on Network Pharmacology.
    Evid Based Complement Alternat Med. 2022;2022:3598856.
    PubMed    
    Abstract available

  56. MISERY L, Bataille A, Talagas M, Le Gall-Ianotto C, et al
    Sensitive Skin Syndrome: A Low-Noise Small-Fiber Neuropathy Related to Environmental Factors?
    Front Pain Res (Lausanne). 2022;3:853491.
    PubMed    
    Abstract available

  57. TOGHA M, Karimitafti MJ, Ghorbani Z, Farham F, et al
    Characteristics and comorbidities of headache in patients over 50 years of age: a cross-sectional study.
    BMC Geriatr. 2022;22:313.
    PubMed    
    Abstract available

  58. ZHOU C, Cheng X, Liu C, Li P, et al
    Interpersonal coordination enhances brain-to-brain synchronization and influences responsibility attribution and reward allocation in social cooperation.
    Neuroimage. 2022;252:119028.
    PubMed    
    Abstract available

  59. YAO F, Wu X, Zhao H, Gan C, et al
    Efficacy of psychological interventions for irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Medicine (Baltimore). 2022;101:e29033.
    PubMed    
    Abstract available

  60. SALAMIN F, Gobin N, Cereda JM, Bonnaud G, et al
    [Irritable bowel syndrome : physiopathology and complementary management].
    Rev Med Suisse. 2022;18:763-768.
    PubMed    
    Abstract available

  61. JIAN J, Nie MT, Xiang B, Qian H, et al
    Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids.
    Front Pharmacol. 2022;13:841132.
    PubMed    
    Abstract available

  62. MUJAGIC Z, Kasapi M, Jonkers DM, Garcia-Perez I, et al
    Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome.
    Gut Microbes. 2022;14:2063016.
    PubMed    
    Abstract available

  63. DUFFY C, Pridgen WL, Whitley RJ
    Gastric herpes simplex virus type 1 infection is associated with functional gastrointestinal disorders in the presence and absence of comorbid fibromyalgia: a pilot case-control study.
    Infection. 2022 Apr 21. pii: 10.1007/s15010-022-01823.
    PubMed    
    Abstract available


  64. A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial [Retraction].
    J Inflamm Res. 2022;15:2381-2382.
    PubMed    
    Abstract available

  65. GAN Y, Huang SL, Luo MQ, Chen M, et al
    Acupuncture in addition to usual care for patients with irritable bowel syndrome: a component network meta-analysis.
    Acupunct Med. 2022 Apr 18:9645284221085280. doi: 10.1177/09645284221085280.
    PubMed    
    Abstract available

  66. G S A
    Biopharmaceutical applications of alpha-galactosidases.
    Biotechnol Appl Biochem. 2022 Apr 18. doi: 10.1002/bab.2349.
    PubMed    
    Abstract available

  67. CHEN T, Chen S, Zheng X, Zhu Y, et al
    The pathological involvement of spinal cord EphB2 in visceral sensitization in male rats.
    Stress. 2022;25:166-178.
    PubMed    
    Abstract available

  68. ZHANG T, Zhang C, Zhang J, Sun F, et al
    Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Front Cell Infect Microbiol. 2022;12:859967.
    PubMed    
    Abstract available

  69. CORDEIRO SANTOS ML, da Silva Junior RT, de Brito BB, Franca da Silva FA, et al
    Non-pharmacological management of pediatric functional abdominal pain disorders: Current evidence and future perspectives.
    World J Clin Pediatr. 2022;11:105-119.
    PubMed    
    Abstract available

  70. SINGHA M, Trejo Paredes C, Alang N, Wu U, et al
    Dangerous dog licks! - A rare case of epidural abscess secondary to Capnocytophaga.
    IDCases. 2022;28:e01483.
    PubMed    
    Abstract available

  71. MAMIEVA Z, Poluektova E, Svistushkin V, Sobolev V, et al
    Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
    World J Gastroenterol. 2022;28:1204-1219.
    PubMed    
    Abstract available

  72. BUBAN T, Sipeki N, Varvolgyi C, Papp M, et al
    A vastagbel-diverticulosis veszelyei es kezelese.
    Orv Hetil. 2022;163:614-623.
    PubMed    
    Abstract available

  73. CHIU YC, Chang WP, Tang GJ, Lan TY, et al
    Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders.
    Respir Med. 2022;197:106833.
    PubMed    
    Abstract available

  74. HOLROYD CB
    Interbrain synchrony: on wavy ground.
    Trends Neurosci. 2022;45:346-357.
    PubMed    
    Abstract available

  75. QUIGLEY EMM
    Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean?
    Aliment Pharmacol Ther. 2022;55:1218-1219.
    PubMed    


  76. BRENNER DM, Harris LA, Chang CH, Waldman SA, et al
    Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed    
    Abstract available

  77. KASSEBAUM-LADEWSKI A, Poppers DM, Brenner DM
    Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed    
    Abstract available

  78. SAYUK GS, Waldman SA, Brenner DM
    Mechanisms of Action of Current Pharmacologic Options for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed    
    Abstract available

  79. HARRIS LA, Chang CH
    Burden of Constipation: Looking Beyond Bowel Movements.
    Am J Gastroenterol. 2022;117.
    PubMed    
    Abstract available

  80. BRENNER DM
    Best Practices for the Management of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation: A Roundtable Discussion and Review.
    Am J Gastroenterol. 2022;117.
    PubMed    


  81. ZHANG X, Xiao X, Yang JL
    Shall we reduce endoscopy in patients with irritable bowel syndrome?
    Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00342.
    PubMed    


  82. SINGH P, Tuck C, Gibson PR, Chey WD, et al
    The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation.
    Am J Gastroenterol. 2022 Apr 8. pii: 00000434-990000000-00347.
    PubMed    
    Abstract available

  83. BRAY NA, Koloski NA, Jones MP, Do A, et al
    Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study.
    Dig Dis Sci. 2022 Apr 1. pii: 10.1007/s10620-022-07464.
    PubMed    
    Abstract available

  84. GANJI L, Shirazi MH, Ebrahimi-Daryani N, Eslami P, et al
    Carriage of CdtB Encoding Campylobacter spp., Salmonella enterica, and Yersinia entercolitica in Patients with Gastroenteritis and Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 Mar 31. pii: 10.1007/s10620-022-07468.
    PubMed    
    Abstract available

  85. HURYCH J, Vodolanova L, Vejmelka J, Drevinek P, et al
    Freezing of faeces dramatically decreases the viability of Blastocystis sp. and Dientamoeba fragilis.
    Eur J Gastroenterol Hepatol. 2022;34:242-243.
    PubMed    


  86. BUSHYHEAD D, Quigley EMM
    Small Intestinal Bacterial Overgrowth, Pathophysiology and its implications for Definition and Management.
    Gastroenterology. 2022 Apr 7. pii: S0016-5085(22)00357.
    PubMed    
    Abstract available

  87. CHONG RIH, Yaow CYL, Loh CYL, Teoh SE, et al
    Vitamin D Supplementation for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2022 Apr 8. doi: 10.1111/jgh.15852.
    PubMed    
    Abstract available

  88. FAN K, Eslick GD, Nair PM, Burns GL, et al
    HUMAN INTESTINAL SPIROCHETOSIS, IRRITABLE BOWEL SYNDROME AND COLONIC POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Gastroenterol Hepatol. 2022 Apr 6. doi: 10.1111/jgh.15851.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;